Toshiharu Kamura
- Reproductive Medicine top 0.1%
- Ovarian cancer diagnosis and treatment 72
- Endometriosis Research and Treatment 16
- Obstetrics and Gynecology top 0.1%
- Endometrial and Cervical Cancer Treatments 72
- Uterine Myomas and Treatments 14
- Oncology top 2%
- Cancer Research top 2%
- Immunology top 5%
- Immunotherapy and Immune Responses 14
-
- Cervical Cancer and HPV Research 26
-
- Intraperitoneal and Appendiceal Malignancies 18
-
- Sarcoma Diagnosis and Treatment 10
- Co-authors
- Takashi NishidaNaoyo NishidaHirohisa YanoMasamichi KojiroKimio UshijimaHiroyuki YoshikawaTsunehisa KakuToshiaki Saito
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Toshiharu Kamura
181 papers receiving 7.3k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Reproductive Medicine 3.1k
- Obstetrics and Gynecology 2.8k
- Oncology 1.5k
- Cancer Research 708
- Immunology 812
Countries citing papers authored by Toshiharu Kamura
This map shows the geographic impact of Toshiharu Kamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiharu Kamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiharu Kamura more than expected).
Fields of papers citing papers by Toshiharu Kamura
This network shows the impact of papers produced by Toshiharu Kamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiharu Kamura. The network helps show where Toshiharu Kamura may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Toshiharu Kamura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 98 | |
| 2 | 2018 | 32 | |
| 3 | 2013 | 0 | |
| 4 | 2013 | 11 | |
| 5 | 2013 | 28 | |
| 6 | 2013 | 12 | |
| 7 | Favourable prognosis with modified dosing of docetaxel and cisplatin in Japanese patients with ovarian cancer. | 2009 | 5 |
| 8 | 2008 | 2 | |
| 9 | 2007 | 6 | |
| 10 | 2003 | 8 | |
| 11 | 2002 | 25 | |
| 12 | [A modified administrated schedule for combination therapy with irinotecan and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical cancer--a report of 2 cases as a pilot study]. | 2001 | 2 |
| 13 | 2001 | 1 | |
| 14 | 2001 | 105 | |
| 15 | 2000 | 17 | |
| 16 | 1999 | 61 | |
| 17 | 1995 | 26 | |
| 18 | [Two cases of atypical polypoid adenomyoma of the uterus]. | 1993 | 2 |
| 19 | 1993 | 18 | |
| 20 | 1985 | 1 |
About Toshiharu Kamura
Toshiharu Kamura is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology, having authored 188 papers that have together received 7.5k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (72 papers), Endometrial and Cervical Cancer Treatments (72 papers), Cervical Cancer and HPV Research (26 papers), Intraperitoneal and Appendiceal Malignancies (18 papers), Endometriosis Research and Treatment (16 papers), Immunotherapy and Immune Responses (14 papers), Uterine Myomas and Treatments (14 papers) and Sarcoma Diagnosis and Treatment (10 papers). The work is most often cited by research in Reproductive Medicine (3.1k citations), Obstetrics and Gynecology (2.8k citations) and Oncology (1.5k citations). Toshiharu Kamura has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Takashi Nishida, Naoyo Nishida, Hirohisa Yano, Masamichi Kojiro, Kimio Ushijima, Hiroyuki Yoshikawa, Tsunehisa Kaku, Toshiaki Saito, Naoki Terakawa and Naoki Tsukamoto. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.